Opening an NPI-verified account
Every Precision Biologics account is tied to a valid NPI number, and a Cleveland pain management or physical medicine practice supplies that number during onboarding before pricing is released. This step is identical across every market Precision Biologics serves; location does not change the verification requirement.
Cleveland
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
277- Pain Medicine
- 138
- Physical Medicine & Rehabilitation
- 139
Confirming regulatory standing first
Before a pain management practice adds a Wharton's jelly or exosome product line, Precision Biologics recommends confirming current standing with the Ohio medical board and reviewing the regulatory framework that applies to the specific product with the practice's own counsel. Precision Biologics is a distributor, not a clinical or legal advisor, and does not weigh in on dosing, protocols, or how a given use is classified.
Lot documentation and sterility testing records
Each lot is tested by a third-party laboratory for sterility and is held in quarantine until it meets internal release criteria, and a verified account can request the resulting certificate of analysis along with a donor eligibility summary before ordering. Pain management practices often request this documentation product line by product line, since Wharton's jelly allografts and exosome products are processed and documented under different parts of the federal regulatory framework.
Cold-chain receiving for Cleveland-area practices
Cryopreserved products are stored at -80 degrees Celsius and shipped overnight on dry ice in validated containers; lyophilized exosome products are shelf-stable and are handled per the insert included with the lot. A practice should check the cold-chain indicator against the shipment on arrival and record the lot identifier at the patient record level, since product use is tracked by lot.
These products are not FDA approved or licensed for any disease or condition. Information here is for licensed healthcare professionals and is not medical or legal advice.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
How does a Cleveland pain management practice open an account with Precision Biologics?+
By providing a valid NPI number for the ordering physician or practice during onboarding. Pricing and ordering access are released only after that record is verified.
What testing documentation can a Cleveland physical medicine practice request for a tissue lot?+
Verified accounts can request the certificate of analysis showing third-party sterility testing results, along with the donor eligibility summary, for the specific lot being considered.
Does Precision Biologics tell a Cleveland practice how to use these products clinically?+
No. Precision Biologics distributes the products and documentation; clinical use, dosing, and protocol decisions remain with the practice and its own counsel and medical board.